Genetic alterations as clonal markers for bladder cancer detection in urine

Journal of Cellular Biochemistry

Volumn 63, Issue SUPPL. 25, 1996, Pages 191-196

  Mao, Li ^a,b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

bladder tumor; cancer screening; molecular markers

Indexed keywords

MICROSATELLITE DNA; TUMOR MARKER;

ARTICLE; BLADDER CANCER; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; GENETIC MARKER; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; MOLECULAR CLONING; POINT MUTATION; PRIORITY JOURNAL; URINALYSIS; BLADDER TUMOR; CELL CLONE; COLORECTAL TUMOR; GENETIC SCREENING; GENETICS; HETEROZYGOTE; REVIEW; URINE;

CLONE CELLS; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; GENETIC MARKERS; GENETIC SCREENING; HETEROZYGOTE; HUMANS; MICROSATELLITE REPEATS; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 0030483991     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(1996)25+<191::AID-JCB27>3.0.CO;2-Q     Document Type: Article

References (39)

1. Wingo PA, Tong T, Bolden S (1995): Cancer statistics. CA Cancer J Clin 45:8-30.
2. Catalona WJ, Dresner SM, Haaff EO (1988): Management of superficial bladder cancer. In Skinner DG, Lieskovsky G (eds): "Diagnosis and Management of Genitourinary Cancer." Philadelphia: WB Saunders, pp 281-284.
3. Koss LG, Deitch D, Ramanathan R, Sherman AB (1985): Diagnostic value of cytology of voided urine. Acta Cytol 29:810-816.
4. Farrow GM (1979): Pathologist's role in bladder cancer. Semin Oncol 6:198-206.
5. Fearon ER, Vogelstein B: A genetic model for colorectal tumorigenesis. Cell 61:757-767.
6. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, Nakamura Y, White R, Smits AMM, Bos JL (1988): Genetic alteration during colorectal-tumor development. N Engl J Med 319:525-532.
7. Barbacid M (1987): ras Genes. Annu Rev Biochem 56:779-827.
8. Fujita J, Srivastava SK, Kraus MH (1985): Frequency of molecular alterations affecting ras proto-oncogenes in human urinary tract tumors. Proc Natl Acad Sci USA 82:3849-3853.
9. Perucca D, Szepetowski P, Simon M-P, Gaudray P (1990): Molecular genetics of human bladder carcinomas. Cancer Genet Cytogenet 49:143-156.
10. Wright C, Mellon K, Johnston P, Lane DP, Harris AL, Horne CHW, Neal DE (1991): Expression of mutant p53, c-erbB-2 and epidermal growth factor receptor in transitional cell carcinoma of the human urinary bladder. Br J Cancer 63:967-970.
11. Lipponen P (1993): Expression of c-erbB-2 oncoprotein in transitional cell bladder cancer. Eur J Cancer 29A: 749-753.
12. Eisenman RN (1989): Nuclear oncogenes. In Weiberg RA (ed): "Oncogenes and the Molecular Origins of Cancer." Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, pp 175-222.
13. Sidransky D, Messing E (1992): Molecular genetics and biochemical mechanisms in bladder cancer. Oncogenes, tumor suppressor genes, and growth factors. Urol Clin North Am 19:629-639.
14. Sarkis AS, Dalbagni G, Cordon-Cardo C, Zhang Z-F, Sheinfeld J, Fair WR, Here HW, Reuter VE (1993): Nuclear overexpression of p53 protein in transitional cell bladder carcinoma: A marker for disease progression. J Natl Cancer Inst 85:53-59.
15. Nigro JM, Baker SJ, Preisinger AC, Jessup JM, Hostetter R, Cleary K, Bigner SH, Davidson N, Baylin S, Devilee P, Glover T, Collins FS, Weston A, Modali R, Harris CC, Vogelstein B (1989): Mutations in the p53 gene occur in diverse human tumour types. Nature 342:705-708.
16. Fujimoto K, Yamada Y, Okajima D, Kakizoe T, Sasaki H, Sugimura T, Terada M (1992): Frequent association of p53 gene mutation in invasive bladder cancer. Cancer Res 52:1393-1398.
17. Cordon-Cardo C, Dalbagni G, Saez GT, Oliva MR, Zhang ZF, Rosai J, Reuter VE, Pellicer A (1994): p53 Mutations in human bladder cancer: Genotypic versus phenotypic patterns. Int J Cancer 56:347-353.
18. Sidransky D, Von Eschenbach A, Tsai CT, Jones P, Summerhayes I, Marshall F, Paul M, Green P, Hamilton SR, Frost P, Vogelstein B (1991): Identification of p53 gene mutations in bladder cancers and urine samples. Science 252:706-709.
19. Cairns P, Proctor AJ, Knowles MA (1991): Loss of heterozygosity at the RB locus is frequent and correlates with muscle invasion in bladder carcinoma. Oncogene 6:2305-2309.
20. Logothetis CJ, Xu H-J, Ro JY, Hu S-X, Sahin A, Ordonez N, Benedict WF (1992): Altered expression of retinoblastoma protein and known prognostic variables in locally advanced bladder cancer. J Natl Cancer Inst 84:1256-1261.
21. Xu HJ, Cairns P, Hu SX, Knowles MA, Benedict WF (1993): Loss of RB protein expression in primary bladder cancer correlates with loss of heterozygosity at the RB locus and tumor progression. Int J Cancer 53:781-784.
22. Hussussian CJ, Struewing JP, Goldstein AM, Higgins PAT, Ally DS, Sheahan MD, Clark WH Jr, Tucker MA, Dracopoli NC (1994): Germline p16 mutations in familial melanoma. Nat Genet 8:15-21.
23. Caldas C, Hahn SA, da Costa LT, Redston MS, Schutte M, Seymour AB, Weinstein CL, Hruban RH, Yeo CJ, Kern SE (1994): Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma. Nat Genet 8:27-32.
24. Cairns P, Mao L, Merlo A, Lee DJ, Schwab D, Eby Y, Tokino K, ven der Riet P, Blaugrund JE, Sidransky D (1994): Rates of p16 (MTS1) mutations in primary tumors with 9p loss. Science 265:415-417.
25. Serrano M, Hannon GJ, Beach D (1993): A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 366:704-707.
26. Nobori T, Miura K, Wu DJ, Lois A, Takabayashi K, Carson DA (1994): Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 368:753-756.
27. Cairns P, Thomas JP, Eby E, Tokino K, Califano J, Merlo A, Mao L, Herath J, Jenkins R, Weatra W, Rutter JL, Buckler A, Gabrielson E, Tockman M, Cho K, Hedrick L, Bova SG, Issacs W, Schwab D, Sidransky D (1995): High frequency of homozygous deletion at p16/ CDKN2 in primary human tumors. Nat Genet 11:210-212.
28. Rosin MP, Cairns P, Epstein JI, Schoenberg MP, Sidransky D (1995): Partial allelotype of carcinoma in situ of the human bladder. Cancer Res 55:5213-5216.
29. Merlo A, Herman JG, Mao L, Lee DJ, Gabrielson E, Burger PC, Baylin SB, Sidransky D (1995): 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nat Med 1:686-692.
30. Dalbagni G, Presti J, Reuter V, Fair WR, Cordon-Cardo C (1993): Genetic alterations in bladder cancer. Lancet 342:469-471.
31. Mao L, Lee DJ, Tockman MS, Erozan YS, Askin F, Sidransky D (1994): Microsatellite alterations as clonal markers for the detection of human cancer. Proc Natl Acad Sci USA 91:9871-9875.
32. Hruban RH, van der Riet P, Erozan YS, Sidransky D (1994): Brief report: Molecular biology and the early detection of carcinoma of the bladder - the case of Hubert H. Humphrey. N Engl J Med 330:1276-1278.
33. Brennan JA, Mao L, Hruban RH, Boyle JO, Eby YJ, Koch WM, Goodman SN, Sidransky D (1995): Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck. N Engl J Med 332:429-435.
34. Huntington Disease Collaborative Research Group (1993): A novel gene containing a trinucleotide repeat that is expanded and unstable on HD chromosomes. Cell 72:971-983.
35. Brook DJ, McCurrach ME, Harley HG, Buckler AJ, Church D, Aburatani H, Hunter K, Stanton VP, Thirion JP, Hudson T, Sohn R, Zemelman B, Snell RG, Rundle SA, Crow S, Davies J, Shelbourne P, Buxton J, Jones C, Juvonen V, Johnson K, Harper PS, Shaw DJ, Housman DE (1992): Molecular basis of myotonic dystrophy: Expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member. Cell 68:799-808.
36. + tumor cells. Cell 75:1227-1236.
37. Knowles MA, Elder PA, Williamson M, Cairns P, Shaw ME, Law MG (1994): Allelotype of human bladder cancer. Cancer Res 54:531-538.
38. Wooster R, Cleton-Jansen AM, Collins N, Mangion J, Cornelis RS, Cooper CS, Gusterson BA, Ponder BA, von Deimling A, Wiestler OD, Cornelisse CJ, Devilee P, Stratton MR (1994): Instability of short tandem repeats (microsatellites) in human cancers. Nat Genet 6:152-156.
39. Mao L, Schoenberg MP, Scicchitano M, Erozan YS, Merlo A, Schwab D, Sidransky D (1996): Molecular detection of primary bladder cancer by microsatellite analysis. Science 271:659-662.